MCID: SBC035
MIFTS: 34

Subacute Cutaneous Lupus Erythematosus malady

Categories: Skin diseases, Rare diseases, Immune diseases

Aliases & Classifications for Subacute Cutaneous Lupus Erythematosus

About this section
Sources:
29ICD10, 30ICD10 via Orphanet, 49Novoseek, 53Orphanet, 67UMLS, 68UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Subacute Cutaneous Lupus Erythematosus:

Name: Subacute Cutaneous Lupus Erythematosus 53
Lupus Erythematosus, Subacute Cutaneous 67
 
Lupus Erythematosus Cutaneous Subacute 49

Characteristics:

Orphanet epidemiological data:

53
subacute cutaneous lupus erythematosus:
Prevalence: 1-9/1000000 (United States)

Classifications:

Orphanet: 53 
Rare skin diseases


External Ids:

Orphanet53 ORPHA163525
ICD10 via Orphanet30 L93.1
UMLS via Orphanet68 C0024140
ICD1029 L93.1

Summaries for Subacute Cutaneous Lupus Erythematosus

About this section
Wikipedia:70 Subacute cutaneous lupus erythematosus (SCLE) is a clinically distinct subset of cases of lupus... more...

MalaCards based summary: Subacute Cutaneous Lupus Erythematosus, also known as lupus erythematosus, subacute cutaneous, is related to hypertrichosis and cutaneous lupus erythematosus. An important gene associated with Subacute Cutaneous Lupus Erythematosus is TRIM21 (Tripartite Motif Containing 21). Affiliated tissues include skin, t cells and lung.

Related Diseases for Subacute Cutaneous Lupus Erythematosus

About this section

Diseases in the Cutaneous Lupus Erythematosus family:

subacute cutaneous lupus erythematosus

Diseases related to Subacute Cutaneous Lupus Erythematosus via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 98)
idRelated DiseaseScoreTop Affiliating Genes
1hypertrichosis29.3ACE, TNF
2cutaneous lupus erythematosus11.0
3lupus erythematosus11.0
4systemic lupus erythematosus10.3
5rheumatoid arthritis10.1
6arthritis10.1
7endocarditis10.1TNF, TRIM21
8tick-borne encephalitis10.1TNF, TRIM21
9porphyria cutanea tarda10.1
10porphyria10.1
11vasculitis10.1
12psoriasis10.1
13pulmonary systemic sclerosis10.1TNF, TRIM21
14submandibular gland disease10.0TNF, TRIM21
15blood group incompatibility10.0TNF, TRIM21
16adult malignant hemangiopericytoma10.0TNF, TRIM21
17discoid lupus erythematosus10.0
18uveoparotid fever9.9ACE, TNF
19acneiform dermatitis9.9ACE, TNF
20post-infectious myocarditis9.9ACE, TNF
21c2 deficiency9.9
22hepatitis9.9
23erythema multiforme9.9
24tinea corporis9.9
25myositis9.9
26neuropathy9.9
27lichen planus9.9
28burns9.9ACE, TNF
29islet cell tumor9.9ACE, TNF
30chromosome 9p deletion syndrome9.9ACE, TNF
31oesophagostomiasis9.9ACE, TNF
32lacrimal system cancer9.9ACE, TNF
33sinusitis9.9ACE, TNF
34discitis9.9ACE, TNF
35alcohol abuse9.9ACE, TNF
36renal fibrosis9.9ACE, TNF
37diphtheria9.9ACE, TNF
38anaerobic pneumonia9.9ACE, TNF
39renal tubular acidosis9.9ACE, TNF
40spinal canal and spinal cord meningioma9.9ACE, TNF
41diabetic encephalopathy9.9ACE, TNF
42lung hilum cancer9.9ACE, TNF
43short bowel syndrome9.9ACE, TNF
44periampullary adenoma9.9ACE, TNF
45laryngeal tuberculosis9.9ACE, TNF
46exocrine pancreatic insufficiency9.8ACE, TNF
47sacral spinal canal and spinal cord meningioma9.8ACE, TNF
48frontal sinus cancer9.8ACE, TNF
49common wart9.8ACE, TNF
50prostate malignant phyllodes tumor9.8ACE, TRIM21

Graphical network of the top 20 diseases related to Subacute Cutaneous Lupus Erythematosus:



Diseases related to subacute cutaneous lupus erythematosus

Symptoms for Subacute Cutaneous Lupus Erythematosus

About this section

Drugs & Therapeutics for Subacute Cutaneous Lupus Erythematosus

About this section

Drugs for Subacute Cutaneous Lupus Erythematosus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Alitretinoinapproved, investigationalPhase 2155300-03-8444795
Synonyms:
(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(7e,9Z,11e,13e)-Retinoic acid
(9cis)-retinoic acid
.beta.-Retinoic acid
187175-63-9
1n4h
302-79-4
5300-03-8
56573-65-0
7005-78-9
9 Cis Retinoic Acid
9(Z)-Retinoic acid
9-CIS-RETINOIC ACID
9-CRA
9-cis RA
9-cis Retinoic Acid
9-cis-RA
9-cis-Retinoic acid
9-cis-Tretinoin
9C-RA
9CRA
A-Acido (Argentina)
A-Vitaminsyre
AC-6824
AC1L9GWO
AC1L9MT9
AC1Q1J2J
AGN 100335
AGN 192013
AGN-192013
AKOS000280845
ALRT 1057
ALRT-1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid, Retinoic
Acid, Vitamin A
Acid, trans-Retinoic
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
Alitretinoin (USAN)
Alitretinoin [USAN]
Alitretinoinum
Alitretinoína
Alitrétinoïne
Atra-IV
Atragen
Atralin
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL-4079
BAL4079
BB_NC-1005
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BML2-E06
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001495
BSPBio_001500
Betarretin
C00777
C15493
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEBI:50648
CHEMBL38
CHEMBL705
CID444795
CID449171
CPD000058245
Cordes VAS [Germany]
Cordes vas
D00094
D014212
D02815
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K17
HMS1361K22
HMS1568D16
HMS1791K17
HMS1791K22
HMS1921D14
HMS1989K17
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033965
IDI1_033970
L000833
LG-100057
 
LGD 100057
LGD 1057
LGD-1057
LMPR01090019
LMPR01090022
LS-1154
LS-1328
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
MolPort-002-507-281
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NCGC00161590-01
NCGC00161590-02
NCGC00161590-03
NCGC00161590-04
NCGC00161590-05
NCGC00161590-06
NCGC00161590-07
NSC 122758
NSC 659772
NSC-122758
NSC-659772
NSC122758
NSC659772
Nexret
PDT-002-002
Panretin
Panretin (TN)
Panretin Gel
Panretyn
Panrexin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
R4643_SIGMA
REA
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retinoate
Retinoic acid
Retinova
Retionic acid
Retisol-A
Ro 1-5488
Ro-04-4079
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
SR-05000013784
SR-05000013784-1
ST057075
STK801887
STOCK1N-38565
Salt, Tretinoin Zinc
Solage
Spectrum5_001746
Spectrum5_001933
Spectrum5_001935
Stieva-A
Stieva-a Forte
TRETINON
Toctino
Tretin M
Tretinoin (TN)
Tretinoin Zinc Salt
Tretinoina
Tretinoine
Tretinoino
Tretinoinum
Tri-Luma
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
UPCMLD-DP097:001
UPCMLD-DP097:002
Vesanoid
Vesanoid (TN)
Vesnaroid
Vitamin A acid
Vitinoin
Zinc Salt, Tretinoin
[3H]Retinoic acid
alitretinoina
alitretinoine
alitretinoinum
all-trans-Tretinoin
b-Retinoic acid
beta-Ra
beta-Retinoic acid
bmse000562
nchembio.106-comp3
nchembio.154-comp2
nchembio861-comp8
trans Retinoic Acid
trans-Retinoic acid
tretinoin
tretinoin liposome
2
Tretinoinapproved, investigational, nutraceuticalPhase 2220302-79-45538
Synonyms:
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
.beta.-Retinoic acid
13497-05-7 (hydrochloride salt)
15-Apo-beta-caroten-15-oic acid
187175-63-9
1n4h
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
302-79-4
5300-03-8
56573-65-0
7005-78-9
9(Z)-Retinoic acid
9-cis-RA
A-Acido (Argentina)
A-Vitaminsyre
A-Vitaminsyre [Denmark]
AC-6824
AC1L9GWO
AC1Q1J2J
AGN 100335
AGN 192013
AKOS000280845
ALRT 1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid A Vit (Belgium, Netherlands)
Acid, Retinoic
Acid, Vitamin A
Acid, all-trans-Retinoic
Acid, beta-all-trans-Retinoic
Acid, trans-Retinoic
Acide retinoique (French) (DSL)
Acide retinoique (french) (dsl)
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
All Trans Retinoic Acid
All Trans-Retinoic Acid
All-trans Retinoic Acid
Alltrans-retinoic acid
Amnesteem
Atra-IV
Atragen
Atralin
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL4079
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001500
Betarretin
C00777
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEMBL38
CID444795
CPD000058245
Claravis
Cordes VAS [Germany]
Cordes vas
D00094
D014212
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K22
HMS1568D16
HMS1791K22
HMS1921D14
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033970
Isotretinoin Retinoic acid
L000833
LGD 100057
LMPR01090019
LS-1154
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
 
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NSC 122758
NSC-122758
NSC122758
Nexret
PDT-002-002
Panretin Gel
Panretyn
Potassium Salt, Tretinoin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
REA
RETINOIC ACID, ALL TRANS
RETINOIC acid
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retin-a
Retinoate
Retinoic acid
Retinoic acid, all-trans- (8CI)
Retinova
Retionic Acid
Retionic acid
Retisol-A
Retisol-a
Ro 1-5488
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
ST057075
Salt, Tretinoin Potassium
Salt, Tretinoin Sodium
Salt, Tretinoin Zinc
Sodium Salt, Tretinoin
Solage
Sotret
Spectrum5_001746
Spectrum5_001933
Stieva-A
Stieva-a
Stieva-a Forte
TRETINON
Tretin M
Tretin m
Tretinoin
Tretinoin (JAN/USP/INN)
Tretinoin (TN)
Tretinoin 0.1% cream or placebo
Tretinoin Potassium Salt
Tretinoin Sodium Salt
Tretinoin Zinc Salt
Tretinoin [USAN:INN:BAN]
Tretinoin/All-Trans Retinoic Acid
Tretinoina
Tretinoina [INN-Spanish]
Tretinoine
Tretinoine (french) (einecs)
Tretinoine [INN-French]
Tretinoino
Tretinoino [INN-Spanish]
Tretinoinum
Tretinoinum [INN-Latin]
Tri-Luma
Trétinoïne
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
Vesanoid
Vesanoid (TN)
Vesanoid, Airol, Renova, Atralin, Retin-A, Avita, Tretinoin
Vesnaroid
Vitamin A acid
Vitinoin
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1
Zinc Salt, Tretinoin
[3H]Retinoic acid
all trans-Retinoic acid
all-(E)-Retinoic acid
all-(e)-Retinoic acid
all-trans-Retinoic acid
all-trans-Tretinoin
all-trans-Vitamin A acid
all-trans-Vitamin A1 acid
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-b-Retinoic acid
all-trans-beta-Retinoic acid
b-Retinoic acid
beta all trans Retinoic Acid
beta-Ra
beta-Retinoic Acid
beta-Retinoic acid
beta-all-trans-Retinoic acid
bmse000562
nchembio.154-comp2
trans Retinoic Acid
trans-Retinoic acid
tretinoin
tretinoin liposome
tretinoine (French) (EINECS)
3Dermatologic AgentsPhase 25674
4Keratolytic AgentsPhase 2420
5tyrosineNutraceuticalPhase 1659
6
Tacrolimusapproved, investigational1074104987-11-3445643, 439492
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
Anhydrous tacrolimus
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
 
FR900506
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus anhydrous
Tacrolimus hydrate
Tacrolimus, anhydrous
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
7
Pimecrolimusapproved, investigational62137071-32-06447131, 17753757
Synonyms:
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-((E)-2-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)-1-methylvinyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,26,26a-hexadecahydro-5,19-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,17,20,21(4H,23H)-tetrone
137071-32-0
33-Epi-chloro-33-desoxyascomycin
33-epi-Chloro-33-desoxyascomycin
ASM 981
ASM-981
ASM-998
CHEMBL1200686
CID6447131
CID6509979
CID6916008
D05480
DB00337
 
Elidel
Elidel (TN)
I06-1252
LS-181798
MolPort-003-666-749
NCGC00167506-01
Pimecrolimus
Pimecrolimus (JAN/USAN/INN)
Pimecrolimus [USAN:INN:BAN]
Pimecrolimusum
S5004_Selleck
SDZ ASM 981
SDZ-ASM 981
SDZ-ASM-981
UNII-7KYV510875
8Immunosuppressive Agents12770
9Calcineurin Inhibitors1597
10Peripheral Nervous System Agents22776
11Anti-Inflammatory Agents10355
12Analgesics11287
13Analgesics, Non-Narcotic6260
14Anti-Inflammatory Agents, Non-Steroidal4295
15Antirheumatic Agents10627

Interventional clinical trials:

idNameStatusNCT IDPhase
1Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus ErythematosusCompletedNCT01294774Phase 2
2To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusCompletedNCT01300208Phase 2
3Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus ErythematosusTerminatedNCT01407679Phase 2
4Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus PatientsRecruitingNCT02927457Phase 1
5Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusTerminatedNCT01389895Phase 1
6Cutaneous Lupus Erythematosus and ElidelUnknown statusNCT00222183
7Pilot Tape Harvesting StudyCompletedNCT02125695
8A Non-drug Study Profiling Cutaneous LupusCompletedNCT01923415Early Phase 1
9A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersCompletedNCT02034344Early Phase 1
10The Human Microbiome in Immune-Mediated DiseasesRecruitingNCT02394964

Search NIH Clinical Center for Subacute Cutaneous Lupus Erythematosus

Genetic Tests for Subacute Cutaneous Lupus Erythematosus

About this section

Anatomical Context for Subacute Cutaneous Lupus Erythematosus

About this section

MalaCards organs/tissues related to Subacute Cutaneous Lupus Erythematosus:

35
Skin, T cells, Lung, Testes, Brain, Colon, Prostate

Animal Models for Subacute Cutaneous Lupus Erythematosus or affiliated genes

About this section

Publications for Subacute Cutaneous Lupus Erythematosus

About this section

Articles related to Subacute Cutaneous Lupus Erythematosus:

(show top 50)    (show all 301)
idTitleAuthorsYear
1
Voriconazole-Induced Subacute Cutaneous Lupus Erythematosus in an Adult With Aspergillosis. (28031137)
2016
2
Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE). (26897388)
2016
3
Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients. (27185425)
2016
4
Subacute cutaneous lupus erythematosus onset preceded by Kikuchi-Fujimoto disease. (24520513)
2014
5
Subacute cutaneous lupus erythematosus presenting as erythroderma. (25484433)
2014
6
Paraneoplastic subacute cutaneous lupus erythematosus associated with cholangiocarcinoma. (25367767)
2014
7
Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. (24547721)
2014
8
A case of subacute cutaneous lupus erythematosus in a patient with mixed connective tissue disease: successful treatment with plasmapheresis and rituximab. (23984162)
2013
9
Subacute cutaneous lupus erythematosus after treatment with capecitabine. (22937906)
2013
10
Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus. (23157783)
2012
11
Subacute Cutaneous Lupus Erythematosus Presenting in Childhood: A Case Report and Review of the Literature. (23106790)
2012
12
Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: case report and literature review. (23056090)
2012
13
Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. (22458771)
2012
14
Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus. (21332692)
2011
15
Oral lesions in four cases of subacute cutaneous lupus erythematosus. (21537822)
2011
16
Variable presentations of subacute cutaneous lupus erythematosus. (20642992)
2010
17
Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses. (20684157)
2010
18
Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus. (19758313)
2010
19
Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. (19289781)
2009
20
Subacute cutaneous lupus erythematosus and interstitial myositis occurring with hepatitis B infection: response to antiviral therapy with lamivudine. (18664991)
2008
21
Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine. (18625380)
2008
22
Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions. (18413415)
2008
23
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. (18176768)
2008
24
Incidental cases of subacute cutaneous lupus erythematosus in association with malignancy. (18955207)
2008
25
Subacute cutaneous lupus erythematosus with bullae associated with porphyria cutanea tarda. (17338797)
2007
26
Subacute cutaneous lupus erythematosus presenting as erythroderma. (17459074)
2007
27
Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy. (17408395)
2007
28
Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative. (16670831)
2007
29
Bullous subacute cutaneous lupus erythematosus. (15115507)
2004
30
Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. (15088316)
2004
31
Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. (12224978)
2002
32
Subacute cutaneous lupus erythematosus associated with phenytoin. (12372089)
2002
33
Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma. (11309033)
2001
34
Etanercept-induced subacute cutaneous lupus erythematosus. (11709621)
2001
35
Erythema multiforme-like subacute cutaneous lupus erythematosus: a new variety? (11028873)
2000
36
Subacute cutaneous lupus erythematosus presenting with generalized poikiloderma. (10642688)
2000
37
Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases. (10773701)
2000
38
Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung. (9094469)
1997
39
Childhood subacute cutaneous lupus erythematosus associated with homozygous complement 2 deficiency. (8747579)
1995
40
Subacute cutaneous lupus erythematosus associated with chronic interstitial pneumonitis. (7607798)
1995
41
Pityriasis rubra pilaris presenting as subacute cutaneous lupus erythematosus. (8243104)
1993
42
Detection of anti-Ro(SSA) antibodies by gel double diffusion and a 'sandwich' ELISA in systemic and subacute cutaneous lupus erythematosus and SjAPgren's syndrome. (1903247)
1991
43
IgG subclasses in the serum and skin in subacute cutaneous lupus erythematosus and neonatal lupus erythematosus. (2250107)
1990
44
Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. (2651477)
1989
45
Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. (2649111)
1989
46
Interferon alfa therapy in severe unresponsive subacute cutaneous lupus erythematosus. (2811978)
1989
47
Subacute cutaneous lupus erythematosus presenting as erythroderma. (2970478)
1988
48
A monoclonal Ro-antibody and the serum of a Ro-positive patient with subacute cutaneous lupus erythematosus (SCLE) react with basal layers of human epidermis. (3147897)
1988
49
Subacute cutaneous lupus erythematosus (SCLE): a distinct subset of LE. (7083626)
1982
50
Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. (7451656)
1981

Variations for Subacute Cutaneous Lupus Erythematosus

About this section

Expression for genes affiliated with Subacute Cutaneous Lupus Erythematosus

About this section
Search GEO for disease gene expression data for Subacute Cutaneous Lupus Erythematosus.

Pathways for genes affiliated with Subacute Cutaneous Lupus Erythematosus

About this section

GO Terms for genes affiliated with Subacute Cutaneous Lupus Erythematosus

About this section

Cellular components related to Subacute Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1recycling endosomeGO:00550379.3EEA1, TNF

Biological processes related to Subacute Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.4TNF, TRIM21
2negative regulation of gene expressionGO:00106298.5ACE, MBD1, TNF

Molecular functions related to Subacute Cutaneous Lupus Erythematosus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1zinc ion bindingGO:00082708.2ACE, EEA1, MBD1, TRIM21

Sources for Subacute Cutaneous Lupus Erythematosus

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet